The DOI matches its Crossref record; 331 of the 331 references it cites were found in a registry or an index.
Immunomodulatory Nanosystems
Open accessAbstract
Immunotherapy has emerged as an effective strategy for the prevention and treatment of a variety of diseases, including cancer, infectious diseases, inflammatory diseases, and autoimmune diseases. Immunomodulatory nanosystems can readily improve the therapeutic effects and simultaneously overcome many obstacles facing the treatment method, such as inadequate immune stimulation, off‐target side effects, and bioactivity loss of immune agents during circulation. In recent years, researchers have continuously developed nanomaterials with new structures, properties, and functions. This Review provides the most recent advances of nanotechnology for immunostimulation and immunosuppression. In cancer immunotherapy, nanosystems play an essential role in immune cell activation and tumor microenvironment modulation, as well as combination with other antitumor approaches. In infectious diseases, many encouraging outcomes from using nanomaterial vaccines against viral and bacterial infections have been reported. In addition, nanoparticles also potentiate the effects of immunosuppressive immune cells for the treatment of inflammatory and autoimmune diseases. Finally, the challenges and prospects of applying nanotechnology to modulate immunotherapy are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–331 of 331
Chen, Y., Chen, M., Zhang, Y., Lee, J. H., Escajadillo, T., Gong, H., Fang, R. H., Gao, W., Nizet, V., & Zhang, L. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701366 · Cited by 144
Tao, Y., Ju, E., Liu, Z., Dong, K., Ren, J., & Qu, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.073 · Cited by 143
Smith, A. M., Perelman, M. S., & Hinchcliffe, M. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27449 · Cited by 143
Treg therapy in transplantation: a general overview
Romano, M., Tung, S. L., Smyth, L. A., & Lombardi, G. (2016) · Transplant International · doi:10.1111/tri.12909 · Cited by 140
Chen, J., Ding, J., Xu, W., Sun, T., Xiao, H., Zhuang, X., & Chen, X. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b02129 · Cited by 138
Self-citationIngale, J., Stano, A., Guenaga, J., Sharma, S. K., Nemazee, D. A., Zwick, M. B., & Wyatt, R. T. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.078 · Cited by 137
Targeting the lymphatics using dendritic polymers (dendrimers)
Kaminskas, L. M., & Porter, C. J. H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.016 · Cited by 133
Keller, S., Wilson, J. T., Patilea-Vrana, G., Kern, H. B., Convertine, A. J., & Stayton, P. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.041 · Cited by 132
Artificial antigen-presenting cells as a tool to exploit the immune `synapse'
Prakken, B. J., Wauben, M. H. M., Genini, D., Samodal, R., Barnett, J., Mendivil, A. A., Leoni, L. M., & Albani, S. (2000) · Nature Medicine · doi:10.1038/82231 · Cited by 130
pH and Reduction Dual-Bioresponsive Polymersomes for Efficient Intracellular Protein Delivery
Zhang, J., Wu, L., Meng, F., Wang, Z., Deng, C., Liu, H., & Zhong, Z. (2011) · Langmuir · doi:10.1021/la203843m · Cited by 130
Yang, H., Ye, L., Guo, X. D., Yang, C., Compans, R. W., & Prausnitz, M. R. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600750 · Cited by 130
McHugh, M. D., Park, J. Y., Uhrich, R., Gao, W., Horwitz, D. A., & Fahmy, T. M. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.003 · Cited by 127
O'Hanley, P. D., Lalonde, G., & Ji, G. (1991) · Infection and Immunity · doi:10.1128/iai.59.3.1153-1161.1991 · Cited by 127
Wang, F., Fang, R. H., Luk, B. T., Hu, C. J., Thamphiwatana, S., Dehaini, D., Angsantikul, P., Kroll, A. V., Pang, Z., Gao, W., et al. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201505231 · Cited by 126
Yang, M., Ding, J., Feng, X., Chang, F., Wang, Y., Gao, Z., Zhuang, X., & Chen, X. (2016) · Theranostics · doi:10.7150/thno.16844 · Cited by 123
Self-citationVaccines and antibiotic resistance
Mishra, R. P. N., Oviedo‐Orta, E., Prachi, P., Rappuoli, R., & Bagnoli, F. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.08.002 · Cited by 121
Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors
Gan, J., Dou, Y., Li, Y., Wang, Z., Wang, L., Liu, S., Li, Q., Yu, H., Liu, C., Han, C., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.06.015 · Cited by 121
Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles
Stano, A., Scott, E. A., Dane, K. Y., Swartz, M. A., & Hubbell, J. A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.024 · Cited by 119
Immunosuppressive and anti‐inflammatory properties of engineered nanomaterials
Ilinskaya, A. N., & Dobrovolskaia, M. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12722 · Cited by 118
Efficient Targeting of Adipose Tissue Macrophages in Obesity with Polysaccharide Nanocarriers
Ma, L., Cross, T.-W., Wallig, M. A., Dobrucki, I. T., Dobrucki, L. W., Nelson, E. R., Swanson, K. S., & Smith, A. M. (2016) · ACS Nano · doi:10.1021/acsnano.6b02878 · Cited by 118
In Situ Capture of Bacterial Toxins for Antivirulence Vaccination
Wei, X., Gao, J., Wang, F., Man, Y. M., Angsantikul, P., Kroll, A. V., Zhou, J., Gao, W., Lu, W., Fang, R. H., et al. (2017) · Advanced Materials · doi:10.1002/adma.201701644 · Cited by 118
Guo, H., Li, F., Xu, W., Chen, J., Hou, Y., Wang, C., Ding, J., & Chen, X. (2018) · Advanced Science · doi:10.1002/advs.201800004 · Cited by 118
Self-citationKorbelik, M., Zhang, W., & Merchant, S. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1047-x · Cited by 117
Highly Integrated Nano-Platform for Breaking the Barrier between Chemotherapy and Immunotherapy
Zheng, D., Chen, J., Zhu, J., Rong, L., Li, B., Lei, Q., Fan, J., Zou, M., Li, C., Cheng, S., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b01432 · Cited by 117
In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance
Pearson, R. M., Casey, L. M., Hughes, K. R., Miller, S. D., & Shea, L. D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.005 · Cited by 117
Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells
Prasad, S., Neef, T., Xu, D., Podojil, J. R., Getts, D. R., Shea, L. D., & Miller, S. D. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.010 · Cited by 116
Gargett, T., Abbas, M. N., Rolan, P. E., Price, J. D., Gosling, K. M., Ferrante, A., Ruszkiewicz, A. R., Atmosukarto, I. I., Altin, J. G., Parish, C. R., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2207-z · Cited by 116
Kageyama, S., Wada, H., Muro, K., Niwa, Y., Ueda, S., Miyata, H., Takiguchi, S., Sugino, S. H., Miyahara, Y., Ikeda, H., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-246 · Cited by 115
LaMothe, R. A., Kolte, P. N., Vo, T., Ferrari, J. D., Gelsinger, T. C., Wong, J., Chan, V., Ahmed, S., Srinivasan, A., Deitemeyer, P., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00281 · Cited by 114
Zhang, Y., Cai, L., Li, D., Lao, Y., Liu, D., Li, M., Ding, J., & Chen, X. (2018) · Nano Research · doi:10.1007/s12274-018-2066-0 · Cited by 114
Self-citationChristensen, D., Henriksen‐Lacey, M., Kamath, A. T., Lindenstrøm, T., Korsholm, K. S., Christensen, J. P., Rochat, A., Lambert, P., Andersen, P. L., Siegrist, C., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.016 · Cited by 113
Steenblock, E. R., Fadel, T. R., Labowsky, M. J., Pober, J. S., & Fahmy, T. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276329 · Cited by 113
Deng, F., He, S., Cui, S., Shi, Y., Tan, Y., Li, Z., Huang, C., Liu, D., Zhi, F., & Peng, L. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy181 · Cited by 112
Self-citationKrishnan, K., Arnone, B., & Buchman, A. L. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21316 · Cited by 111
Mitchell, P., Thatcher, N., Socinski, M. A., Wasilewska-Teśluk, E., Horwood, K., Szczęsna, A., Martin, C. M., Ragulin, Y. А., Zukin, M., Helwig, C., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv104 · Cited by 111
Kosmides, A. K., Meyer, R. A., Hickey, J. W., Aje, K., Cheung, K. N., Green, J. J., & Schneck, J. P. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.038 · Cited by 111
Lin, L. C. W., Chattopadhyay, S., Lin, J., & Hu, C. J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701395 · Cited by 109
Self-reinforced endocytoses of smart polypeptide nanogels for “on-demand” drug delivery
Ding, J., Xu, W., Zhang, Y., Sun, D., Xiao, C., Liu, D., Zhu, X., & Chen, X. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.029 · Cited by 105
Self-citationBerinstein, N. L., Karkada, M., Oza, A. M., Odunsi, K. O., Villella, J., Nemunaitis, J. J., Morse, M. A., Pejovic, T. B., Bentley, J., Buyse, M. E., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1026529 · Cited by 103
Heo, R., Park, J. S., Jang, H. J., Kim, S.-H., Shin, J. M., Suh, Y. D., Jeong, J. H., Jo, D., & Park, J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.057 · Cited by 103
Bennewitz, N. L., & Babensee, J. E. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.08.023 · Cited by 101
Toll like receptors in diseases of the lung
Kovach, M. A., & Standiford, T. J. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.05.013 · Cited by 100
Regulatory T Cells in Radiotherapeutic Responses
Schaue, D., Xie, M. W., Ratikan, J. A., & McBride, W. H. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00090 · Cited by 99
Rampling, T., Ewer, K., Bowyer, G., Bliss, C. M., Edwards, N. J., Wright, D., Payne, R., Venkatraman, N., de Barra, E., Snudden, C. M., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw244 · Cited by 99
Current status and challenges of cytokine pharmacology
Zídek, Z., Anzenbacher, P., & Kmoníčková, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00206.x · Cited by 96
Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
Hamilton, E. P., Blackwell, K., Hobeika, A. C., Clay, T. M., Broadwater, G., Ren, X.-R., Chen, W. R., Castro, H. J., Lehmann, F. F., Spector, N. L., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-28 · Cited by 96
Role of nanotechnology in HIV/AIDS vaccine development
Liu, Y., & Chen, C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.010 · Cited by 93
The scope of nanoparticle therapies for future metastatic melanoma treatment
Bombelli, F. B., Webster, C. A., Moncrieff, M. D., & Sherwood, V. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70333-4 · Cited by 92
Kono, K., Mimura, K., & Kiessling, R. W. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.207 · Cited by 91
Berinstein, N. L., Karkada, M., Morse, M. A., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-156 · Cited by 90
Immunosuppressive Drug TherapyPreprint
Hartono, C., Muthukumar, T., & Suthanthiran, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015487 · Cited by 90
Polymer nanoparticles as adjuvants in cancer immunotherapy
Li, S., Feng, X., Wang, J., He, L., Wang, C., Ding, J., & Chen, X. (2018) · Nano Research · doi:10.1007/s12274-018-2124-7 · Cited by 90
Self-citationTargeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival
Bahmani, B., Uehara, M., Jiang, L., Ordikhani, F., Banouni, N., Ichimura, T., Solhjou, Z., Furtmüller, G. J., Brandacher, G., Álvarez, D., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120923 · Cited by 90
Lell, B., Agnandji, S., von Glasenapp, I., Haertle, S., Oyakhiromen, S., Issifou, S., Vekemans, J., Leach, A., Lievens, M., Dubois, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007611 · Cited by 89
Polyion complex micelles with gradient pH-sensitivity for adjustable intracellular drug delivery
Chen, J., Ding, J., Zhang, Y., Xiao, C., Zhuang, X., & Chen, X. (2014) · Polymer Chemistry · doi:10.1039/c4py01149j · Cited by 89
Self-citationWu, Y.-L. L. C., Park, K., Soo, R. A., Sun, Y. K., Tyroller, K., Wages, D. S., Ely, G., Yang, J. C., & Mok, T. S. K. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-430 · Cited by 89
Qiu, F. X., Becker, K. W., Knight, F. C., Baljon, J. J., Sevimli, S., Shae, D., Gilchuk, P., Joyce, S., & Wilson, J. T. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.052 · Cited by 88
Anti-inflammatory effects of hyaluronan in arthritis therapy: Not just for viscosity
Masuko, K., Murata, M., Yudoh, K., Kato, T., & Nakamura, H. (2009) · International Journal of General Medicine · doi:10.2147/ijgm.s5495 · Cited by 87
Schiff base bond-linked polysaccharide–doxorubicin conjugate for upregulated cancer therapy
Feng, X., Li, D., Han, J., Zhuang, X., & Ding, J. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.03.201 · Cited by 86
Self-citationKang, H., Jung, H. J., Kim, S., Wong, S. H. D., Lin, S., Li, G., Dravid, V. P., & Bian, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b02226 · Cited by 86
Ding, J., Xiao, C., Li, Y., Cheng, Y., Wang, N., He, C., Zhuang, X., Zhu, X., & Chen, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.006 · Cited by 85
Self-citationXian, L., Georgess, D., Huso, T. H., Cope, L., Belton, A., Chang, Y.-T., Kuang, W., Gu, Q.-H., Zhang, X., Senger, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms15008 · Cited by 85
Horowitz, A., Hafalla, J. C. R., King, E. C., Lusingu, J., Dekker, D. M., Leach, A. J., Moris, P., Cohen, J., Vekemans, J., Villafana, T. L., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102710 · Cited by 84
Yang, M., Ding, J., Zhang, Y., Chang, F., Wang, J., Gao, Z., Zhuang, X., & Chen, X. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb02479j · Cited by 83
Self-citationRajendrakumar, S. K., Uthaman, S., Cho, C.-S., & Park, I. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00460 · Cited by 82
Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells
Jones, R. B., Mueller, S., Kumari, S., Vrbanac, V. D., Genel, S., Tager, A. M., Allen, T. M., Walker, B. D., & Irvine, D. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.048 · Cited by 81
Scavenger Receptor Type B1 and Lipoprotein Nanoparticle Inhibit Myeloid-Derived Suppressor Cells
Plebanek, M. P., Bhaumik, D., Bryce, P. J., & Thaxton, C. S. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0981 · Cited by 80
Askling, H. H., Rombo, L., van Vollenhoven, R., Hallén, I., Thörner, Å., Nordin, M., Herzog, C., & Kantele, A. (2014) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2014.01.005 · Cited by 78
Applications and perspectives of nanomaterials in novel vaccine development
Shen, Y., Hao, T., Ou, S., Hu, C., & Chen, L. (2017) · MedChemComm · doi:10.1039/c7md00158d · Cited by 78
Gutzmer, R., Rivoltini, L., Levchenko, E., Testori, A., Utikal, J. S., Ascierto, P. A., Демидов, Л. В., Grob, J., Ridolfi, R., Schadendorf, D., et al. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000068 · Cited by 76
Cech, P. G., Aebi, T., Shomari, M., Mpina, M., Machunda, E. B., Westerfeld, N., Stoffel, S. A., Zurbriggen, R., Pluschke, G., Tanner, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022273 · Cited by 68
Nanoparticle-based Strategies for Cancer Immunotherapy and Immunodiagnostics
Grimaldi, A., Incoronato, M., Salvatore, M., & Soricelli, A. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0208 · Cited by 68
Reprogramming macrophage orientation by microRNA 146b targeting transcription factor IRF5
Peng, L., Zhang, H., Hao, Y., Xu, F., Yang, J., Zhang, R., Lu, G., Zheng, Z., Cui, M., Qi, C.-F., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.041 · Cited by 67
Advances in Stimuli‐Responsive Polypeptide Nanogels
Jiang, Z., Chen, J., Cui, L., Zhuang, X., Ding, J., & Chen, X. (2018) · Small Methods · doi:10.1002/smtd.201700307 · Cited by 67
Self-citationShvedova, A. A., Tkach, A. V., Kisin, E. R., Khaliullin, T. O., Stanley, S., Gutkin, D. W., Star, A., Chen, Y., Shurin, G. V., Kagan, V. E., et al. (2012) · Small · doi:10.1002/smll.201201470 · Cited by 66
Butts, C. A., Murray, R. N., Smith, C. J., Ellis, P. M., Jasas, K., Maksymiuk, A. W., Goss, G. D., Ely, G., Beier, F., & Soulières, D. (2010) · Clinical Lung Cancer · doi:10.3816/clc.2010.n.101 · Cited by 65
Ding, J., Shi, F., Li, D., Chen, L., Zhuang, X., & Chen, X. (2013) · Biomaterials Science · doi:10.1039/c3bm60024f · Cited by 63
Self-citationPavot, V., Climent, N., Rochereau, N., García, F., Genin, C., Tiraby, G., Vernejoul, F., Pérouzel, É., Lioux, T., Verrier, B., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.034 · Cited by 63
Xu, W., Ding, J., Li, L., Xiao, C., Zhuang, X., & Chen, X. (2015) · Chemical Communications · doi:10.1039/c5cc01371b · Cited by 61
Self-citationReduction-Responsive Polypeptide Micelles for Intracellular Delivery of Antineoplastic Agent
Xu, W., Ding, J., & Chen, X. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00950 · Cited by 61
Self-citationSterling, S., Kireta, S., McInnes, S. J. P., Kette, F. D., Sivanathan, K. N., Kim, J., Cueto-Diaz, E. J., Cunin, F., Durand, J., Drogemuller, C., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b01625 · Cited by 61
Moyle, P. M., Dai, W. H., Zhang, Y., Batzloff, M. R., Good, M. F., & Tóth, I. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500108b · Cited by 60
Román, R. G., Jensen, K. J., Jensen, S. S., Leo‐Hansen, C., Jespersen, S., Te, D., Rodrigues, C. M., Janitzek, C. M., Vinner, L., Katzenstein, T. L., et al. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0076 · Cited by 54
All-transretinoic acid in the treatment of pediatric acute promyelocytic leukemia
Masetti, R., Vendemini, F., Zama, D., Biagi, C., Gasperini, P., & Pession, A. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.101 · Cited by 51
Cancer immunotherapy making headway
Matsiko, A. (2018) · Nature Materials · doi:10.1038/s41563-018-0091-8 · Cited by 51
Agnandji, S. T., Fendel, R., Mestré, M., Janssens, M., Vekemans, J., Held, J., Gnansounou, F., Haertle, S., von Glasenapp, Oyakhirome, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018559 · Cited by 50
Managing the risks of immunosuppression
Riminton, S., Hartung, H., & Reddel, S. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328346d47d · Cited by 50
Xiong, Y., Gao, W., Xia, F., Sun, Y., Sun, L., Wang, X., Ben, S., Turvey, S. E., Yang, H. Y., & Li, Q. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800510 · Cited by 50
Aoki, M., Ueda, S., Nishikawa, H., Kitano, S., Hirayama, M., Ikeda, H., Toyoda, H., Tanaka, K., Kanai, M., Takabayashi, A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.018 · Cited by 49
Radiation as Immunomodulator: Implications for Dendritic Cell-Based Immunotherapy
Roses, R. E., Datta, J., & Czerniecki, B. J. (2014) · Radiation Research · doi:10.1667/rr13495.1 · Cited by 49
Treg inducing adjuvants for therapeutic vaccination against chronic inflammatory diseases
Keijzer, C., van der Zee, R., van Eden, W., & Broere, F. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00245 · Cited by 49
Li, D., Zhang, G., Xu, W., Wang, J., Wang, Y., Qiu, L., Ding, J., & Yang, X. (2017) · Theranostics · doi:10.7150/thno.19538 · Cited by 49
Self-citationNosratabadi, R., Rastin, M., Sankian, M., Haghmorad, D., & Mahmoudi, M. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.04.001 · Cited by 48
Liu, Y., Balachandran, Y. L., Li, D., Shao, Y., & Jiang, X. (2016) · ACS Nano · doi:10.1021/acsnano.5b08025 · Cited by 47
Paclitaxel nanoparticle awakens immune system to fight against cancer
Tang, W., Yang, J., Yuan, Y., Zhao, Z., Lian, Z., & Liang, G. (2017) · Nanoscale · doi:10.1039/c6nr09895a · Cited by 47
Acid-sensitive dextran prodrug: A higher molecular weight makes a better efficacy
Li, D., Han, J., Ding, J., Chen, L., & Chen, X. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.12.070 · Cited by 46
Self-citationKarlsson, I., Brandt, L., Vinner, L., Kromann, I., Andreasen, L. V., Andersen, P. L., Gerstoft, J., Kronborg, G., & Fomsgaard, A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.12.005 · Cited by 45
Yu, B., Mao, Y., Yuan, Y., Yue, C., Wang, X., Mo, X. M., Jarjoura, D. G., Paulaitis, M. E., Lee, R. J., Byrd, J. C., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.063 · Cited by 44
Warimwe, G. M., Fletcher, H. A., Olotu, A., Agnandji, S. T., Hill, A. V. S., Marsh, K., & Bejon, P. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-184 · Cited by 42
Macromolecule nanotherapeutics: approaches and challenges
Tyagi, P., & Santos, J. L. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.017 · Cited by 42
Wang, Y., Song, W., Hu, M., An, S., Xu, L., Li, J., Kinghorn, K., Liu, R., & Huang, L. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201802847 · Cited by 42
Self-citationLeveraging biomaterials for cancer immunotherapy: targeting pattern recognition receptors
Song, W., Das, M., Xu, Y., Si, X., Zhang, Y., Tang, Z., & Chen, X. (2019) · Materials Today Nano · doi:10.1016/j.mtnano.2019.100029 · Cited by 42
Self-citationLi, D., Sun, H. Y., Ding, J., Tang, Z., Zhang, Y., Xu, W., Zhuang, X., & Chen, X. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.06.041 · Cited by 41
Self-citationBowyer, G., Grobbelaar, A., Rampling, T., Venkatraman, N., Morelle, D., Ballou, R. W., Hill, A. V. S., & Ewer, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01660 · Cited by 41
Immunological risk factors for infection after immunosuppressive and biologic therapies
Carbone, J., del Pozo, N., Gallego, A., & Sarmiento, E. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.178 · Cited by 40
Slingluff, C. L., Petroni, G. R., Olson, W. C., Smolkin, M. E., Chianese‐Bullock, K. A., Mauldin, I. S., Smith, K. T., Deacon, D. H., Varhegyi, N., Donnelly, S. B., et al. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1770-9 · Cited by 39
McQuade, J. L., Homsi, J., Torres-Cabala, C. A., Bassett, R. L., Popuri, R. M., James, M. L., Vence, L. M., & Hwu, W. (2018) · BMC Cancer · doi:10.1186/s12885-018-5193-9 · Cited by 39
Klein, O., Davis, I. D., McArthur, G. A., Chen, L., Haydon, A. M., Parente, P., Dimopoulos, N., Jackson, H. M., Xiao, K., Maraskovsky, E., et al. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1656-x · Cited by 37
Yang, J., Shim, S., Nguyen, T. Q., Kim, E.-H., Kim, K. J., Lim, Y. T., Sung, M., Webby, R. J., & Poo, H. (2017) · Scientific Reports · doi:10.1038/srep44839 · Cited by 37
Tazaki, T., Tabata, K., Ainai, A., Ohara, Y., Kobayashi, S., Ninomiya, T., Orba, Y., Mitomo, H., Nakano, T., Hasegawa, H., et al. (2018) · RSC Advances · doi:10.1039/c8ra01690a · Cited by 36
Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives
Cecco, S., Muraro, E., Giacomin, E., Martorelli, D., Lazzarini, R., Baldo, P., & Dolcetti, R. (2010) · Current Cancer Drug Targets · doi:10.2174/156800911793743664 · Cited by 35
The HMGA1-COX-2 axis: A key molecular pathway and potential target in pancreatic adenocarcinoma
Hillion, J., Smail, S. S., Cello, F. D., Belton, A., Shah, S. N., Huso, T. H., Schuldenfrei, A., Nelson, D. M., Cope, L., Campbell, N. R., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.05.005 · Cited by 35
Draz, M. S., Wang, Y., Chen, F. F., Xu, Y., & Shafiee, H. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201604139 · Cited by 35
Avidity of Anti-Circumsporozoite Antibodies following Vaccination with RTS,S/AS01E in Young Children
Olotu, A., Clément, F., Jongert, E., Vekemans, J., Njuguna, P., Ndungu, F. M., Marsh, K., Leroux-Roels, G. G., & Bejon, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115126 · Cited by 34
Survivors Remorse: antibody‐mediated protection against HIV ‐1
Lewis, G. K., Pazgier, M., & DeVico, A. L. (2017) · Immunological Reviews · doi:10.1111/imr.12510 · Cited by 33
Beneficial liaisons: radiobiology meets cellular and molecular biology
Coleman, C. N. (1993) · Radiotherapy and Oncology · doi:10.1016/0167-8140(93)90179-c · Cited by 32
Wang, L., Chang, T. Z., He, Y., Kim, J., Wang, S., Mohan, T., Berman, Z., Tompkins, S. M., Tripp, R. A., Compans, R. W., et al. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.09.001 · Cited by 32
Limentani, S. A., Campone, M., Dorval, T., Curigliano, G., BOER, R. D., Vogel, C. L., White, S. C., Bachelot, T., Canon, J.-L. R., Disis, M. L., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3751-x · Cited by 31
Bühler, S., Jaeger, V. K., Adler, S., Bannert, B., Brümmerhoff, C., Ciurea, A., Distler, O., Franz, J. K., Gabay, C., Hagenbuch, N., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/kez045 · Cited by 30
Gong, H., Xiang, J., Xu, L., Song, X., Dong, Z., Peng, R., & Liu, Z. (2015) · Nanoscale · doi:10.1039/c5nr06081h · Cited by 27
Rossmann, E. D., Österborg, A., Löfvenberg, E., Choudhury, A., Forssmann, U., von Heydebreck, A., Schröder, A., & Mellstedt, H. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29918 · Cited by 24
Antivirulence Agents Against MRSA
Shoham, M. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.43 · Cited by 23
Treg Cells As Potential Cellular Targets for Functionalized Nanoparticles in Cancer Therapy
Jonuleit, H., Bopp, T., & Becker, C. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0197 · Cited by 21
Cohen, A. D., Lendvai, N. K., Nataraj, S. E., Imai, N., Jungbluth, A. A., Tsakos, I., Rahman, A. H., Mei, A. H.-C., Singh, H., Zarychta, K., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0198 · Cited by 20
Herck, K. V., Hens, A., Coster, I. D., Vertruyen, A., Tolboom, J. T. B. M., Sarnecki, M., & Damme, P. V. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000616 · Cited by 15
Witte, D., Cunliffe, N. A., Turner, A., Ngulube, E., Ofori‐Anyinam, O., Vekemans, J., Chimpeni, P., Lievens, M., Wilson, T. P., Njirammadzi, J., et al. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001937 · Cited by 14
Loew-Baselli, A., Pavlova, B. G., Fritsch, S., Pöllabauer, E.-M., Draxler, W., Kistner, O., Behre, U., Angermayr, R., Neugebauer, J., Kirsten, K., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.039 · Cited by 12
Heesen, L., Jabulowsky, R. A., Loquai, C., Utikal, J. S., Gebhardt, C., Hassel, J. C., Kaufmann, R., Pinter, A., Derhovanessian, E., Diken, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx711.030 · Cited by 10
DeGregorio, M. W., Soe, L., & Wolf, M. (2014) · PubMed Central · doi:10.3978/j.issn.2072-1439.2014.05.15 · Cited by 9
Cebon, J. S., McArthur, G. A., Chen, W., Davis, I. D., Gore, M. E., Thompson, J. F., Millward, M., Findlay, M. P. N., Dunbar, R., Ottensmeier, C. H. H., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.9050 · Cited by 6
Vaccine Therapy in NSCLC: a Review
Malhotra, J. D., O’Dea, D., & Gomez, J. E. (2015) · Lung Cancer Management · doi:10.2217/lmt.14.43 · Cited by 1
Cited by
Chang, M., Wang, M., Wang, M., Shu, M., Ding, B., Li, C., Pang, M., Cui, S., Hou, Z., & Lin, J. (2019) · Advanced Materials · doi:10.1002/adma.201905271 · Cited by 484
Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment
Zhang, M., Hu, W., Cai, C., Wu, Y., Li, J., & Dong, S. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100223 · Cited by 394
Biocompatibility of nanomaterials and their immunological properties
Kyriakides, T. R., Raj, A., Tseng, T. H., Xiao, H., Nguyen, R., Mohammed, F. S., Halder, S., Xu, M., Wu, M. J., Bao, S., et al. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe5fa · Cited by 389
Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Zhang, J., Lin, Y., Lin, Z., Wei, Q., Qian, J., Ruan, R., Jiang, X., Hou, L., Song, J., Ding, J., et al. (2022) · Advanced Science · doi:10.1002/advs.202103444 · Cited by 292
Self-citationSong, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 259
Metadata
- Authors
- Feng, X., Xu, W., Li, Z., Song, W., Ding, J., & Chen, X.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2019-06-21
- Volume
- 6
- Issue
- 17
- Pages
- 1900101-1900101
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W4211179700
- Cited by
- 363
- References
- 331
- FWCI
- 16.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.